Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Clinical Pharmacology in Drug Development|June 24, 2025
Disposition and Absolute Bioavailability of Oral Imlunestrant in Healthy Women: A Phase 1, Open-Label StudyAmita Datta-Mannan, Boris Czeskis, Elaine Shanks, et al.Mabs|February 20, 2015
Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokineticsAmita Datta-Mannan, Arunkumar Thangaraju, Donmienne Leung, et al.Biochemistry|June 27, 2019
Modulation of the Biophysical Properties of Bifunctional Antibodies as a Strategy for Mitigating Poor PharmacokineticsAmita Datta-Mannan, Robin M Brown, Jonathan Fitchett, et al.Pharmaceutical Research|September 1, 2022
Identification of a Multi-Component Formulation for Intestinal Delivery of a GLP-1/Glucagon Co-agonist PeptideHuyen Tran, Phenil J Patel, Aktham Aburub, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2012
FcRn affinity-pharmacokinetic relationship of five human IgG4 antibodies engineered for improved in vitro FcRn binding properties in cynomolgus monkeysAmita Datta-Mannan, Chi-Kin Chow, Craig Dickinson, et al.Journal of Clinical Pharmacology|July 3, 2026
Evaluation of Pharmacokinetics and Safety of Imlunestrant in Participants with Hepatic ImpairmentAmita Datta-Mannan, Stephanie White, Elaine Shanks, et al.Molecular Biology of the Cell|October 10, 2008
Neonatal Fc receptor mediates internalization of Fc in transfected human endothelial cellsNancy A Goebl, Clifford M Babbey, Amita Datta-Mannan, et al.Clinical Therapeutics|December 5, 2024
Evaluation of Pharmacokinetics of Lebrikizumab in Healthy Individuals After Subcutaneous Administration Using a Prefilled Syringe or Autoinjector in a Phase 1 Randomized StudyAmita Datta-Mannan, Brian Moser, Wen Xu, et al.Mabs|June 4, 2020
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodiesAmita Datta-Mannan, Selina Estwick, Chen Zhou, et al.Clinical Pharmacology and Therapeutics|January 31, 2024
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled StudyAmita Datta-Mannan, Arie Regev, David E Coutant, et al.Pageof 4